argus

Akums Drugs and Pharmaceuticals Limited

NSE: AKUMSINE09XN0102312,300 Cr

Timeline

Time (IST)TypeMEventSrc
03 Sept, 03:00 pmother1Akums Drugs received a voluntary ESG rating of 65 for FY2025-26 from NSE Sustainability Ratings & Analytics Limited based on publicly available information.nse
24 Aug, 03:08 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Update On Schedule Of The Investors/Analysts Meet To Be Held On August 25, 2026bse
24 Aug, 03:03 pmAkums Drugs and Pharmaceuticals Limited has informed the Exchange about an Update on schedule of the Investors/ Analysts Meet to be held on August 25, 2026nse
13 Aug, 02:49 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
13 Aug, 02:40 pmAkums Drugs and Pharmaceuticals Limited has informed the Exchange about Transcriptnse
10 Aug, 03:45 pmAkums Drugs and Pharmaceuticals Limited has informed the Exchange about Link of Recordingnse
10 Aug, 03:43 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
10 Aug, 02:59 pmMonitoring Agency Report for the quarter ended June 30, 2026nse
08 Aug, 05:16 pmAkums Drugs and Pharmaceuticals Limited has informed the Exchange about Presentationnse
08 Aug, 05:14 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
08 Aug, 05:01 pmAkums Drugs and Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 08, 2026, titled "Press Release".nse
08 Aug, 04:13 pmAkums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Un-audited Financial Results for the Quarter ended 30th June, 2026'.nse
08 Aug, 03:59 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Un-Audited Financial Results For The Quarter Ended 30Th June, 2026bse
08 Aug, 03:51 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended 30Th June, 2026bse
08 Aug, 03:46 pmAkums Drugs and Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
05 Aug, 06:46 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Board Meeting Intimation for Un-Audited (Standalone & Consolidated) Financial Results For The Quarter Ended On 30Th June, 2026bse
23 Jul, 11:19 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Acquisitionbse
23 Jul, 11:15 pmIntimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Acquisition of Oriflame India s Manufacturing businessnse
04 Jul, 06:00 pmUpdate on penalty imposed by the Deputy Commissioner of State Tax, Gujarat, on Maxcure Nutravedics Limited, wholly owned subsidiary of the Companynse
19 Jun, 10:53 amAkums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Notice and Integrated Annual Report for the Financial Year 2025-26 to those members who have not registered their e-mail ID s'.nse
18 Jun, 06:22 pmAkums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for the Financial Year 2025-26'.nse
18 Jun, 06:00 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Reg. 34 (1) Annual Report.bse
18 Jun, 05:32 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Notice Of The 22Nd Annual General Meetingbse
16 Jun, 11:17 amNewspaper Advertisement- Information regarding 22nd AGM and Final & Special Dividendnse
10 Jun, 02:38 pminvestor_meet1Company intimates the schedule for investor/analyst meetings (con-call/interaction).nse
03 Jun, 07:03 pmIntimation of Schedule of the Investor/Analysts Meetnse
22 May, 11:30 amReceipt of Assessment Order(s) by certain subsidiaries from Income Tax Departmentnse
21 May, 12:17 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
21 May, 12:12 pmTranscript of Investors/Analysts Conference Call held for un-audited financial results of Q4 FY 2025-26 and audited financial results for FY 2025-26nse
20 May, 07:06 pmAkums Drugs and Pharmaceuticals Limited has informed the Exchange about receipt of Assessment Order(s) from Income Tax Departmentnse
18 May, 05:02 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
18 May, 04:56 pmLink of Audio Recording of Investor/Analysts Conference Callnse
18 May, 12:06 pmUpdate on Disruption of Operationsnse
16 May, 02:45 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
16 May, 02:32 pmUpdate on Disruption in Operations at some of the manufacturing sites at Haridwarnse
14 May, 05:36 pmAkums Drugs and Pharmaceuticals Limited has informed the Exchange about Investor Presentationnse
14 May, 05:31 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
14 May, 05:19 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Monitoring Agency Reportbse
14 May, 05:17 pmMonitoring Agency Report for the quarter ended 31st March, 2026nse
14 May, 04:34 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
14 May, 04:32 pmAkums Drugs and Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "Press Release".nse
14 May, 04:20 pmIntimation of Disruption in Operations at some of the manufacturing sites at Haridwarnse
14 May, 02:26 pmAkums Drugs and Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 03-Jul-2026.nse
14 May, 02:18 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Corporate Action-Board approves Dividendbse
14 May, 02:12 pmChanges in Senior Management Personnelnse
14 May, 02:10 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Change in Managementbse
14 May, 02:07 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Change in Managementbse
14 May, 02:05 pmAkums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Change in Managementbse
14 May, 02:02 pmAppointment of Internal Auditors for the FY 2026-27nse
14 May, 01:59 pmRe-appointment of Cost Auditors for the FY 2026-27nse